The FP7 European Union funded NANOMAL PROJECT is developing a simple, rapid and affordable point-of-care (POC) handheld diagnostic device to confirm The device should provide the same quality of result as a referral laboratory, fraction of the time and cost. Each device could cost about the price of a smart phone initially, may be issued… Continue reading
Author: Garrett
Nanomaterials
Anti-malarial interventions. In addition to improving immediate patient outcomes, the project will allow the researchers to build a better picture of levels of drug resistance in stricken areas. It will also give them information on population impacts of anti-malarial interventions. Clinical trials of the device are expected to begin within three years, after which it… Continue reading
Simple to complex: a molecular perspective
The !5.2million (£4million) Nanomal project – launched today – is planning to provide an affordable hand-held diagnostic device to swiftly detect malaria infection and parasites’ drug resistance. It was set up in response to increasing signs that the malaria parasite is mutating to resist the most powerful class of anti-malaria drugs, artemisinins. The European Commission… Continue reading
Dimensionality in nanomaterials
It will allow healthcare workers in remote rural areas to deliver effective drug treatments to counter resistance more quickly, potentially saving lives. Optimising individual treatments for patients (personalizing treatment) Assessing the epidemiology of drug resistance in malaria endemic areas(identifying emerging drug resistance in real-time) Assessing population impacts of anti-malarial interventions
Biomimetic approaches
The device – the size and shape of a mobile phone – will use a range of latest proven nanotechnologies to rapidly analyse the parasite DNA from a blood sample. It will then provide a malaria diagnosis and comprehensive screening for drug susceptibility in less than 20 minutes, while the patient waits. With immediately available… Continue reading